Screener
Microbot Medical MBOT Proceeds From Exercise Of Options
Proceeds From Exercise Of Options at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept MBOT:ProceedsFromExerciseOfOptions.
The source filing: Microbot Medical’s 10-K, filed March 26, 2026.
- Filed
- Mar 26, 2026, 4:30 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001493152-26-012935
| Line item | 2025 / For the Years Ended December 31, | 2024 / For the Years Ended December 31, |
|---|---|---|
| Net cash flows (used in) provided by investing activities | (72,384) | 1,537 |
| Financing activities: | ||
| Issuance of common stock and warrants, net of issuance costs | 86,239 | 7,936 |
| Exercise of options | 1 | - |
| Net cash flows provided by financing activities | 86,240 | 7,936 |
| Increase in cash, cash equivalents and restricted cash | 810 | 646 |
| Cash, cash equivalents and restricted cash at beginning of year | 3,163 | 2,517 |
| Cash, cash equivalents and restricted cash at ending of year | $3,973 | $3,163 |
Item 16. Form 10-K Summary
FAQ
- What is Microbot Medical's proceeds from exercise of options?
- Microbot Medical (MBOT) reported proceeds from exercise of options of $250 in Q4 2025.
- What does proceeds from exercise of options mean?
- Proceeds From Exercise Of Options as reported by Microbot Medical, Inc. Common Stock.
Ask your AI about Microbot Medical's proceeds from exercise of options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude